Precision Neuroscience

Precision Neuroscience is a mission-driven company developing and commercializing minimally invasive brain-computer interfaces (BCI) to restore independence for people with paralysis and address neurological conditions. Founded in 2021, it focuses on a high-resolution cortical surface array implant that does not penetrate brain tissue, aiming to treat conditions like refractory epilepsy, blindness, paralysis, and cognitive impairments.

  • Digital Health
  • Medtech
  • Neuroscience
  • Healthcare & Life Sciences

1

Round

1

Industry

3

Tags

Sep 24, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Sep 24, 2026

    $250M

    Series C+

    Led by Ackman Oxman Institute

    • ARK Invest
    • Ackman Oxman Institute
    • B Capital
    • Duquesne Family Office
    • Hitachi Ventures
    • Invus
    • JSL Health Capital
    • Korea Investment Partners
    • Mirae Asset Capital
    • Mubadala Capital
    • Pershing Square Inc.

    Article coming soon.

Pricing

Research Precision Neuroscience — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Precision Neuroscience is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational